Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Salivary dysfuncTion After Radioiodine Treatment

NCT04876287 is registered in ClinicalTrials.gov with French Nuclear Safety and Radiation Protection Authority (ASNR) as lead sponsor.

NCT NCT04876287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04876287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Salivary dysfuncTion After Radioiodine Treatment
Lead sponsor
French Nuclear Safety and Radiation Protection Authority (ASNR)
Phase
Observational
Overall status
Completed
Start date
September 2, 2020
Completion date
April 26, 2021
Enrollment
138 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thyroid cancer